Követés
Kornél Király
Kornél Király
Semmelweis Egyetem, Farmakológiai és Farmakoterápiás Intézet
E-mail megerősítve itt: net.sote.hu
Cím
Hivatkozott rá
Hivatkozott rá
Év
Central P2Y12 receptor blockade alleviates inflammatory and neuropathic pain and cytokine production in rodents
G Horváth, F Gölöncsér, C Csölle, K Király, RD Andó, M Baranyi, ...
Neurobiology of disease 70, 162-178, 2014
962014
DAMGO and 6β-glycine substituted 14-O-methyloxymorphone but not morphine show peripheral, preemptive antinociception after systemic administration in a mouse visceral pain …
M Al-Khrasani, M Spetea, T Friedmann, P Riba, K Király, ...
Brain research bulletin 74 (5), 369-375, 2007
452007
The dipeptidyl peptidase IV (CD26, EC 3.4. 14.5) inhibitor vildagliptin is a potent antihyperalgesic in rats by promoting endomorphin-2 generation in the spinal cord
K Király, AM Lambeir, J Szalai, A Szentirmay, W Luyten, I Barna, Z Puskár, ...
European journal of pharmacology 650 (1), 195-199, 2011
422011
Glycine transporter inhibitors: A new avenue for managing neuropathic pain
M Al-Khrasani, A Mohammadzadeh, M Balogh, K Király, S Barsi, B Hajnal, ...
Brain Research Bulletin 152, 143-158, 2019
352019
Peri, pre and postnatal morphine exposure: exposure-induced effects and sex differences in the behavioural consequences in rat offspring
J Timár, M Sobor, KP Király, S Gyarmati, P Riba, M Al-Khrasani, S Fürst
Behavioural pharmacology 21 (1), 58-68, 2010
352010
Nocistatin and nociceptin given centrally induce opioid-mediated gastric mucosal protection
ZS Zádori, N Shujaa, L Köles, KP Király, K Tekes, K Gyires
Peptides 29 (12), 2257-2265, 2008
322008
Glial cell type-specific changes in spinal dipeptidyl peptidase 4 expression and effects of its inhibitors in inflammatory and neuropatic pain
K Király, M Kozsurek, E Lukácsi, B Barta, A Alpár, T Balázsa, C Fekete, ...
Scientific Reports 8 (1), 3490, 2018
302018
The central versus peripheral antinociceptive effects of μ-opioid receptor agonists in the new model of rat visceral pain
M Al-Khrasani, E Lackó, P Riba, K Király, M Sobor, J Timár, S Mousa, ...
Brain research bulletin 87 (2-3), 238-243, 2012
302012
A comprehensive time course and correlation analysis of indomethacin-induced inflammation, bile acid alterations and dysbiosis in the rat small intestine
B Lázár, SB László, B Hutka, AS Tóth, A Mohammadzadeh, E Berekméri, ...
Biochemical Pharmacology 190, 114590, 2021
252021
Alterations in prodynorphin gene expression and dynorphin levels in different brain regions after chronic administration of 14-methoxymetopon and oxycodone-6-oxime
KP Király, P Riba, C D’Addario, M Di Benedetto, D Landuzzi, S Candeletti, ...
Brain research bulletin 70 (3), 233-239, 2006
242006
New morphine analogs produce peripheral antinociception within a certain dose range of their systemic administration
E Lackó, P Riba, Z Giricz, A Váradi, L Cornic, M Balogh, K Király, ...
Journal of Pharmacology and Experimental Therapeutics 359 (1), 171-181, 2016
232016
Interactions between NSAIDs, opioids and the gut microbiota-future perspectives in the management of inflammation and pain
ZS Zádori, K Király, M Al-Khrasani, K Gyires
Pharmacology & Therapeutics 241, 108327, 2023
212023
Efficacy-based perspective to overcome reduced opioid analgesia of advanced painful diabetic neuropathy in rats
M Balogh, F Zádor, ZS Zádori, M Shaqura, K Király, A Mohammadzadeh, ...
Frontiers in Pharmacology 10, 347, 2019
212019
On the role of peripheral sensory and gut mu opioid receptors: Peripheral analgesia and tolerance
S Fürst, ZS Zádori, F Zádor, K Király, M Balogh, SB László, B Hutka, ...
Molecules 25 (11), 2473, 2020
202020
A new potent analgesic agent with reduced liability to produce morphine tolerance
K Kiraly, FF Caputi, A Hanuska, E Kató, M Balogh, L Köles, M Palmisano, ...
Brain research bulletin 117, 32-38, 2015
192015
Spinal interaction between the highly selective μ agonist DAMGO and several δ opioid receptor ligands in naive and morphine-tolerant mice
AK Szentirmay, KP Király, N Lenkey, E Lackó, M Al-Khrasani, ...
Brain research bulletin 90, 66-71, 2013
192013
Does the effect of morphine challenge change on maternal behaviour of dams chronically treated with morphine during gestation and further on during lactation?
M Sobor, J Timár, P Riba, KP Király, S Gyarmati, M Al-Khrasani, S Fürst
Pharmacology Biochemistry and Behavior 95 (3), 367-374, 2010
182010
Immunoreactive endomorphin 2 is generated extracellularly in rat isolated L4, 5 dorsal root ganglia by DPP-IV
AZ Rónai, K Király, A Szebeni, E Szemenyei, Z Prohászka, Z Darula, ...
Regulatory peptides 157 (1-3), 1-2, 2009
172009
Pharmacological evidence on augmented antiallodynia following systemic co-treatment with GlyT-1 and GlyT-2 inhibitors in rat neuropathic pain model
A Mohammadzadeh, PP Lakatos, M Balogh, F Zádor, DÁ Karádi, ...
International Journal of Molecular Sciences 22 (5), 2479, 2021
152021
Selegiline reduces adiposity induced by high‐fat, high‐sucrose diet in male rats
CT Nagy, G Koncsos, ZV Varga, T Baranyai, S Tuza, F Kassai, AJ Ernyey, ...
British Journal of Pharmacology 175 (18), 3713-3726, 2018
152018
A rendszer jelenleg nem tudja elvégezni a műveletet. Próbálkozzon újra később.
Cikkek 1–20